Heterologous protein production and delivery systems for Lactococcus lactis

Genetics and Molecular Research

Volumn 2, Issue 1, 2003, Pages 102-111

  Nouaille, Sébastien ^a   Ribeiro, Luciana A ^a,b   Miyoshi, Anderson ^b   Pontes, Daniela ^b   Le Loir, Yves ^a   Oliveira, Sergio Costa ^b   Langella, Philippe ^a   Azevedo, Vasco ^b  

^a CEMAGREF   (France)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antigens; Cytokines; Lactococcus lactis; Mucosal vaccine; Secretion

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CYTOKINE; LIVE VACCINE; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; LACTIC ACID BACTERIUM; LACTOCOCCUS LACTIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING;

ANIMALS; ANTIGENS; CYTOKINES; GENE EXPRESSION REGULATION; GENETIC VECTORS; IMMUNITY, MUCOSAL; LACTOCOCCUS LACTIS; MICE; RECOMBINANT PROTEINS; VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOCOCCUS; LACTOCOCCUS LACTIS; STREPTOCOCCUS;

EID: 0345186677     PISSN: 16765680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Andersson, H. and von Heijne, G. (1991). A 30-residue-long "export initiation domain" adjacent to the signal sequence is critical for protein translocation across the inner membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA 88: 9751-9754.
2. Arnau, J., Hjerl-Hansen, E. and Israelsen, H. (1997). Heterologous gene expression of bovine plasmin in Lactococcus lactis. Appl. Microbiol. Biotechnol. 48: 331-338.
3. Bermudez-Humaran, L.G., Langella, P., Miyoshi, A., Gruss, A., Guerra, R.T., Montes de Oca-Luna, R. and Le Loir, Y. (2002). Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl. Environ. Microbiol. 68: 917-922.
4. Bermudez-Humaran, L.H., Langella, P., Cortez-Perez, N., Gruss, A., Tamez-Guerra, R.S., Oliveira, S.C., Montes de Oca-Luna, R. and Le Loir, Y. (2003). Intranasal administration of recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect. Immun. 71: (in press).
5. Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S.D. and Sorokin, A. (2001). The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 11: 731-753.
6. Boyaka, P.N., Lillard Jr., J.W. and McGhee, J. (1999). Interleukin 12 and innate molecules for enhanced mucosal immunity. Immunol. Res. 20: 207-217.
7. Chatel, J.M., Langella, P., Adel-Patient, K., Commissaire, J., Wal, J.M. and Corthier, G. (2001). Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin. Diagn. Lab. Immunol. 8: 545-551.
8. de Ruyter, P.G., Kuipers, O.P. and de Vos, W.M. (1996). Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62: 3662-3667.
9. de Vos, W.M. (1999). Gene expression systems for lactic acid bacteria. Curr. Opin. Microbiol. 2: 289-295.
10. de Vos, W.M. and Gasson, M.J. (1989). Structure and expression of the Lactococcus lactis gene for phospho-beta-galactosidase (lacG) in Escherichia coli and L. lactis. J. Gen. Microbiol. 135: 1833-1846.
11. de Vos, W.M. and Vaughan, E.E. (1994). Genetics of lactose utilization in lactic acid bacteria. FEMS Microbiol. Rev. 15: 217-237.
12. de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C. and Schrezenmeir, J. (2001). Probiotics compensation for lactase insufficiency. Am. J. Clin. Nutr. 73: 421S-429S.
13. Dickinson, B.L. and Clements, J.D. (1995). Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63: 1617-1623.
14. Dietrich, G., Hess, J., Gentschev, I., Knapp, B., Kaufmann, S.H. and Goebel, W. (2001). From evil to good: a cytolysin in vaccine development. Trends Microbiol. 9: 23-28.
15. Dieye, Y., Usai, S., Clier, F., Gruss, A. and Piard, J.C. (2001). Design of a protein-targeting system for lactic acid bacteria. J. Bacteriol. 183: 4157-4166.
16. Drouault, S., Corthier, G., Ehrlich, S.D. and Renault, P. (2000). Expression of the Staphylococcus hyicus lipase in Lactococcus lactis. Appl. Environ. Microbiol. 66: 588-598.
17. Drouault, S., Juste, C., Marteau, P., Renault, P. and Corthier, G. (2002). Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl. Environ. Microbiol. 68: 3166-3168.
18. Eichenbaum, Z., Federle, M.J., Marra, D., de Vos, W.M., Kuipers, O.P., Kleerebezem, M. and Scott, J.R. (1998). Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl. Environ. Microbiol. 64: 2763-2769.
19. Ellis, R.W. (2001). Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19: 2681-2687.
20. Enouf, V., Langella, P., Commissaire, J., Cohen, J. and Corthier, G. (2001). Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl. Environ. Microbiol. 67: 1423-1428.
21. Fischetti, V.A., Medaglini, D. and Pozzi, G. (1996). Gram-positive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotechnol. 7: 659-666.
22. Foss, D.L. and Murtaugh, M.P. (2000). Mechanisms of vaccine adjuvanticity at mucosal surfaces. Anim. Health Res. Rev. 1: 3-24.
23. Gaeng, S., Scherer, S., Neve, H. and Loessner, M.J. (2000). Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis. Appl. Environ. Microbiol. 66: 2951-2958.
24. Glenting, J., Madsen, S.M., Vrang, A., Fomsgaard, A. and Israelsen, H. (2002). A plasmid selection system in Lactococcus lactis and its use for gene expression in L. lactis and human kidney fibroblasts. Appl. Environ. Microbiol. 68: 5051-5056.
25. Grangette, C., Muller-Alouf, H., Goudercourt, D., Geoffroy, M.C., Turneer, M. and Mercenier, A. (2001). Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69: 1547-1553.
26. Gunneriusson, E., Samuelson, P., Uhlen, M., Nygren, P.A. and Stahl, S. (1996). Surface display of a functional single-chain Fv antibody on staphylococci. J. Bacteriol. 178: 1341-1346.
27. Hultgren, O.H., Stenson, M. and Tarkowski, A. (2001). Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res. 3: 41-47.
28. Israelsen, H., Madsen, S.M., Vrang, A., Hansen, E.B. and Johansen, E. (1995). Cloning and partial characterization of regulated promoters from Lactococcus lactis Tn917-lacZ integrants with the new promoter probe vector, pAK80. Appl. Environ. Microbiol. 61: 2540-2547.
29. Jennings, R., Simms, J.R. and Heath, A.W. (1998). Adjuvants and delivery systems for viral vaccines - mechanisms and potential. Dev. Biol. Stand. 92: 19-28.
30. Koprowski 2nd, H., Levine, M.M., Anderson, R.J., Losonsky, G., Pizza, M. and Barry, E.M. (2000). Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect. Immun. 68: 4884-4892.
31. Kovarik, J., Martinez, X., Pihlgren, M., Bozzotti, P., Tao, M.H., Kipps, T.J., Wild, T.F., Lambert, P.H. and Siegrist, C.A. (2000). Limitations of in vivo IL-12 supplementation strategies to induce Th1 early life responses to model viral and bacterial vaccine antigens. Virology 268: 122-131.
32. Kuipers, O.P., de Ruyter, P.G., Kleerebezem, M. and de Vos, W.M. (1997). Controlled overproduction of proteins by lactic acid bacteria. Trends Biotechnol. 15: 135-140.
33. Langella, P. and Le Loir, Y. (1999). Heterologous protein secretion in Lactococcus lactis: a novel antigen delivery system. Braz. J. Med. Biol. Res. 32: 191-198.
34. Le Loir, Y., Gruss, A., Ehrlich, S.D. and Langella, P. (1998). A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J. Bacteriol. 180: 1895-1903.
35. Le Loir, Y., Nouaille, S., Commissaire, J., Bretigny, L., Gruss, A. and Langella, P. (2001). Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis. Appl. Environ. Microbiol. 67: 4119-4127.
36. Lee, M.H., Roussel, Y., Wilks, M. and Tabaqchali, S. (2001). Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19: 3927-3935.
37. Lee, S.J., Kim, D.M., Bae, K.H., Byun, S.M. and Chung, J.H. (2000). Enhancement of secretion and extracellular stability of staphylokinase in Bacillus subtilis by wprA gene disruption. Appl. Environ. Microbiol. 66: 476-480.
38. Madsen, S.M., Arnau, J., Vrang, A., Givskov, M. and Israelsen, H. (1999). Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol. Microbiol. 32: 75-87.
39. Makrides, S.C. (1996). Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60: 512-538.
40. McGhee, J.R. and Mestecky, J. (1990). In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. Infect. Dis. Clin. North. Am. 4: 315-341.
41. Medaglini, D., Pozzi, G., King, T.P. and Fischetti, V.A. (1995). Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. USA 92: 6868-6872.
42. Medaglini, D., Ciabattini, A., Spinosa, M.R., Maggi, T., Marcotte, H., Oggioni, M.R. and Pozzi, G. (2001). Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19: 1931-1939.
43. Medina, E. and Guzman, C.A. (2001). Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19: 1573-1580.
44. Neuman, M.G., Shear, N.H., Bellentani, S. and Tiribelli, C. (1998). Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells. Gastroenterology 115: 157-166.
45. Nguyen, T.N., Hansson, M., Stahl, S., Bachi, T., Robert, A., Domzig, W., Binz, H. and Uhlen, M. (1993). Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination. Gene 128: 89-94.
46. Norton, P.M., Brown, H.W. and Le Page, W. (1994). The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle. FEMS Microbiol. Lett. 120: 249-256.
47. Norton, P.M., Le Page, R.W. and Wells, J.M. (1995). Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system. Folia Microbiol. 40: 225-230.
48. O'Sullivan, D.J., Walker, S.A., West, S.G. and Klaenhammer, T.R. (1996). Development of an expression strategy using a lytic phage to trigger explosive plasmid amplification and gene expression. Biotechnology 14: 82-87.
49. Perdigon, G., Fuller, R. and Raya, R. (2001). Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2: 27-42.
50. Piard, J.C., Hautefort, I., Fischetti, V.A., Ehrlich, S.D., Fons, M. and Gruss, A. (1997). Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J. Bacteriol. 179: 3068-3072.
51. Pizza, M., Giuliani, M.M., Fontana, M.R., Monaci, E., Douce, G., Dougan, G., Mills, K.H., Rappuoli, R. and Del Giudice, G. (2001). Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19: 2534-2541.
52. Pozzi, G., Contorni, M., Oggioni, M.R., Manganelli, R., Tommasino, M., Cavalieri, F. and Fischetti, V.A. (1992). Delivery and expression of a heterologous antigen on the surface of streptococci. Infect. Immun. 60: 1902-1907.
53. Pugsley, A.P. (1993). The complete general secretory pathway in gram-negative bacteria. Microbiol. Rev. 57: 50-108.
54. Puohiniemi, R., Simonen, M., Muttilainen, S., Himanen, J.P. and Sarvas, M. (1992). Secretion of the Escherichia coli outer membrane proteins OmpA and OmpF in Bacillus subtilis is blocked at an early intracellular step. Mol. Microbiol. 6: 981-990.
55. Ravn, P., Arnau, J., Madsen, S.M., Vrang, A. and Israelsen, H. (2000). The development of TnNuc and its use for the isolation of novel secretion signals in Lactococcus lactis. Gene 242: 347-356.
56. Reveneau, N., Geoffroy, M.C., Locht, C., Chagnaud, P. and Mercenier, A. (2002). Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20: 1769-1777.
57. Ribeiro, L.A., Azevedo, V., Le Loir, Y., Oliveira, S.C., Dieye, Y., Piard, J.C., Gruss, A. and Langella, P. (2002). Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl. Environ. Microbiol. 68: 910-916.
58. Robinson, K., Chamberlain, L.M., Schofield, K.M., Wells, J.M. and Le Page, R.W. (1997). Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15: 653-657.
59. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E. and Mattila-Sandholm, T. (1998). Demonstration of safety of probiotics - a review. Int. J. Food Microbiol. 44: 93-106.
60. Sanders, J.W., Venema, G., Kok, J. and Leenhouts, K. (1998). Identification of a sodium chloride-regulated promoter in Lactococcus lactis by single-copy chromosomal fusion with a reporter gene. Mol. Gen. Genet. 257: 681-685.
61. Scheppler, L., Vogel, M., Zuercher, A.W., Zuercher, M., Germond, J.E., Miescher, S.M. and Stadler, B.M. (2002). Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20: 2913-2920.
62. Schotte, L., Steidler, L., Vandekerckhove, J. and Remaut, E. (2000). Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb. Technol. 27: 761-765.
63. Seegers, J.F. (2002). Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol. 20: 508-515.
64. Shata, M.T., Stevceva, L., Agwale, S., Lewis, G.K. and Hone, D.M. (2000). Recent advances with recombinant bacterial vaccine vectors. Mol. Med. Today 6: 66-71.
65. Shu, Q. and Gill, H.S. (2002). Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 34: 59-64.
66. Sorensen, K.I., Larsen, R., Kibenich, A., Junge, M.P. and Johansen, E. (2000). A food-grade cloning system for industrial strains of Lactococcus lactis. Appl. Environ. Microbiol. 66: 1253-1258.
67. Stahl, S. and Uhlen, M. (1997). Bacterial surface display: trends and progress. Trends Biotechnol. 15: 185-192.
68. Steidler, L., Wells, J.M., Raeymaekers, A., Vandekerckhove, J., Fiers, W. and Remaut, E. (1995). Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 61: 1627-1629.
69. Steidler, L., Robinson, K., Chamberlain, L., Schofield, K.M., Remaut, E., Le Page, R.W. and Wells, J.M. (1998). Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66: 3183-3189.
70. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. and Remaut, E. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355.
71. Tjalsma, H., Bolhuis, A., Jongbloed, J.D., Bron, S. and van Dijl, J.M. (2000). Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev 64: 515-547.
72. von Heijne, G. (1990). The signal peptide. J. Membr. Biol. 115: 195-201.
73. Wells, J.M., Wilson, P.W., Norton, P.M., Gasson, M.J. and Le Page, R.W. (1993a). Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8: 1155-1162.
74. Wells, J.M., Wilson, P.W., Norton, P.M. and Le Page, R.W. (1993b). A model system for the investigation of heterologous protein secretion pathways in Lactococcus lactis. Appl. Environ. Microbiol. 59: 3954-3959.
75. Wu, S.C., Ye, R., Wu, X.C., Ng, S.C. and Wong, S.L. (1998). Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J. Bacteriol. 180: 2830-2835.
76. Wu, X.C., Lee, W., Tran, L. and Wong, S.L. (1991). Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 173: 4952-4958.